Volume 15, Number 8—August 2009
Lobomycosis in Man and Lobomycosis-like Disease in Bottlenose Dolphin, Venezuela
We report 1 case of lobomycosis caused by Lacazia loboi in a fisherman and 1 case of lobomycosis-like disease in a bottlenose dolphin (Tursiops truncatus) along the coast of Venezuela. These findings suggest that the marine environment is a likely habitat for L. loboi and a reservoir for infection.
Lobomycosis (lacaziosis) is a chronic, granulomatous, fungal infection of the skin and subcutaneous tissues that affects humans and members of the family Delphinidae (1–6). It is caused by the noncultivable yeast-like organism (Lacazia loboi) of the order Onygenales (7).
Rare in humans, lobomycosis was first reported in Recife, Brazil, in 1930 (1) and subsequently in other countries in South and Central America, where it seems to be endemic (4). It was also recently reported in Europe, Canada, the United States, and South Africa, mostly in persons who had traveled to Central or South America or had contact with an infected dolphin (8–10). Geographic and climatic conditions associated with endemic human lobomycosis are those of tropical continental areas that are generally located 200–250 m above sea level and characterized by dense vegetation, annual rainfall <2,000 mm, mean temperature of 24°C, and mean relative humidity >75% (4).
Cases of lobomycosis have been found in bottlenose dolphins (Tursiops truncatus) and Guiana dolphins (Sotalia guianensis) in North and South America since the 1970s and are being increasingly reported (2,3,5,6). The disease in these mammals is characterized by white to pink, verrucous lesions, often in pronounced relief that may ulcerate and form large plaques. Lobomycosis-like disease, a syndrome pathoanatomically consistent with lobomycosis but for which a histologic diagnosis is lacking, has been found in coastal bottlenose dolphins from Colombia, Ecuador, Peru, and Brazil, Guiana dolphins in Brazil (5,11), and Indo-Pacific bottlenose dolphins (T. aduncus) in the tropical lagoon of Mayotte in the Indian Ocean (12).
L. loboi cells from lesions in bottlenose dolphins were smaller than those found in infected tissues in humans, which suggests that the organism may not be identical in the 2 hosts (13). Serologic data have indicated that dolphins and humans are infected with similar L. loboi strains (14). The possibility of humans acquiring lobomycosis from dolphins appears low; only 1 documented case of disease transmission from a rescued dolphin to its attendant occurred in the early 1970s (9). The ecology of lobomycosis in humans and odontocetes seems to be unconnected. Infections occur mostly in persons inhabiting the Amazon Basin and in inshore and estuarine dolphins in North and South America (3–6). We report cases of lobomycosis in a fisherman and lobomycosis-like disease in a bottlenose dolphin along the coast of Venezuela.
A 62-year-old fisherman from the central coast of Venezuela (Puerto Cruz and Chichiriviche de la Costa, 10°32′N, 67°14′W) was examined during a fieldwork expedition in March 2008. He had extensive lesions on the left ear and recalled that his illness began when he was ≈52 years of age and had accidentally injured the posterior portion of the helix of that ear with a fishhook. A small, solitary, hard nodule subsequently developed and was later accompanied by similar satellite lesions that tended to become confluent and form harder nodules, sometimes hyperchromic with flat and shiny surfaces (Figure 1, panel A). These nodules slowly invaded the entire free border, posterior aspect, and lobule of the ear and caused occasional pruritus and a tingling sensation. Because of the diffuse infiltration of the ear, the condition was initially diagnosed as diffuse cutaneous leishmaniasis or lepromatous leprosy.
Microscopic findings included a granulomatous reaction indicated by lymphohistiocytic elements with large numbers of multinucleated Langhan-type giant cells and numerous isolated yeast-like organisms with a birefringent membrane isolated or in chains alternating with some piriform elements showing simple gemation (Figure 1, panels B, C). The patient refused otoplasty and was treated with itraconazole; some nodules partially regressed.
On June 28, 2004, an adult male, likely inshore, bottlenose dolphin, which had recently died, was found on a beach of La Restinga National Park (11°01′N, 64°10′W) on Margarita Island, Venezuela. The dolphin was 3.8 m long and was emaciated. Several teeth were missing, especially at the distal end of the beak, and an 8-cm Conchoderma auritum stalked barnacle was attached to the right 10th mandibular tooth. The dolphin had severe lobomycosis-like disease with a large number of white, gray, and pink proliferating, congregating lesions, some bleeding, with keloidal and verrucous characteristics that formed rosettes on the beak, back, flanks, dorsal fin, tailstock, and tail (Figure 2). The dorsal fin was severely affected and the asymmetric distribution of the lesions caused the fin to bend. Granulomas extended into the oral cavity between the maxillar teeth and the palate. Unfortunately, because of a variety of factors, including a lack of field sampling capabilities, presence of crowd, and limited beach access for transport, no necropsy was conducted and no samples were available. However, the severe emaciation suggested that the dolphin had a chronic debilitating disease. Whether its poor health status favored the wide dissemination of lobomycosis-like disease or whether lobomycosis-like disease was the primary undermining factor remains unknown.
We report lobomycosis in a fisherman and lobomycosis-like disease in a bottlenose dolphin along the coast of Venezuela. The fisherman likely contracted the disease from the marine environment after pathogen inoculation with a fishing hook. He had never visited the Amazon Basin. Although the human and dolphin cases were probably not related, they suggest the role of the marine environment as a likely natural habitat for L. loboi and as a reservoir for infection. Along the central coasts of Venezuela and Margarita Island, temperatures range from 22°C to 28°C, annual rainfall ranges from 0 mm to 500 mm (Margarita Island) or >500 mm (central coast), and the mean relative humidity is ≈50%.
Many aspects of transmission, pathogenesis, and ecology of lobomycosis are still poorly understood. Transmission of lobomycosis among Delphinidae may occur by contact, as suggested by the endemic status of the disease in bottlenose dolphins in the Indian River Lagoon in Florida, USA, and possible transmission from mother to calf in an Indo-Pacific bottlenose dolphin from the Mayotte Lagoon (5,12). Humans may also acquire the infection through rare contact with infected free-ranging Delphinidae. The disease signs and pathologic changes are similar in humans and dolphins. In humans, lobomycosis is associated with an apparent partial deficit of cell-mediated immunity and no alterations of humoral immunity (15). In dolphins, the disease is related to a substantial decrease in CD4+ helper T-lymphocytes and CD19+ and CD21+ B cells (6). Lesions are also similar in humans and cetaceans, although they tend to be larger in cetaceans. These lesions cover a wide and pleiomorphic clinical spectrum, ranging from the typical smooth and shiny nodular lesions with keloidal aspect to the extensive and confluent verrucous lesions. They occur predominately on the most exposed and cooler areas (4,6): i.e., head, back, dorsal fin, flanks, caudal peduncle, and tail in dolphins; and lower limbs, outer ears, upper limbs, and face in humans.
The apparent emergence of lobomycosis, lobomycosis-like disease, and other skin diseases in coastal cetaceans from South America and the Indian Ocean (5,11,12) is cause for concern. This emergence may be indicative of increased biological contamination and environmental changes, including climatic changes worldwide, which may represent a potential threat to human health.
Dr Bermudez is a biologist and marine mammal veterinarian at Cetacean Research Center in Margarita, Venezuela. His research interests include cetacean diseases and wildlife conservation.
We thank the Instituto Nacional de Parques office of La Restinga National Park for providing access to this park, and Koen Van Waerebeek and 2 anonymous referees for making constructive comments on the manuscript.
The Cetacean Research Center is supported by E/S Los Robles and Consolidada de Ferrys.
- Lobo JO. Nova especies de blastomycose. Bras Med. 1930;44:1227.
- De Vries GA, Laarman JJ. A case of Lobo’s disease in the dolphin Sotalia guianensis. Aquat Mamm. 1973;1:26–33.
- Caldwell DK, Caldwell MC, Woodard JC, Ajello L, Kaplan W, McLure HM. Lobomycosis as a disease of the Atlantic bottle-nosed dolphin (Tursiops truncatus Montagu, 1821). Am J Trop Med Hyg. 1975;24:105–14.
- Paniz-Mondolfi AE, Reyes-Jaimes O, Dávila-Jones L. Lobomycosis in Venezuela. Int J Dermatol. 2007;46:180–5.
- Van Bressem M-F, Van Waerebeek K, Reyes JC, Felix F, Echegaray M, Siciliano S, A preliminary overview of skin and skeletal diseases and traumata in small cetaceans from South American waters. Lat Am J Aquat Mamm; (LAJAM). 2007;6:7–42.
- Murdoch ME, Reif JS, Mazzoil M, McCulloch SD, Fair PA, Bossart GD. Lobomycosis in bottlenose dolphins (Tursiops truncatus) from the Indian River Lagoon, Florida: estimation of prevalence, temporal trends, and spatial distribution. EcoHealth. 2008;5:289–97.
- Herr RA, Tarcha EJ, Taborda PR, Taylor JW, Ajello L, Mendoza L. Phylogenetic analysis of Lacazia loboi places this previously uncharacterized pathogen within the dimorphic Onygenales. J Clin Microbiol. 2001;39:309–14.
- Symmers WS. A possible case of Lobo’s disease acquired in Europe from a bottle-nosed dolphin (Tursiops truncatus). Bull Soc Pathol Exot Filiales. 1983;76:777–84.
- Burns RA, Toy JS, Woods C, Padhye AA, Warnock DW. Report of the first human case of lobomycosis in the United States. J Clin Microbiol. 2000;38:1283–5.
- Al-Daraji WI, Husain E, Robson A. Lobomycosis in African patients. Br J Dermatol. 2008;159:234–6.
- Van Bressem M-F, Santos MO, Oshima JE. Skin diseases in Guiana dolphins (Sotalia guianensis) from the Paranaguá estuary, Brazil: a possible indicator of a compromised marine environment. Mar Environ Res. 2009;67:63–8.
- Kiszka J, Van Bressem M-F, Pusineri C. Lobomycosis-like disease and other skin conditions in Indo-Pacific bottlenose dolphins Tursiops aduncus from the Indian Ocean. Dis Aquat Organ. 2009;84:151–7.
- Haubold EM, Cooper CR Jr, Wen JW, Mcginnis MR, Cowan DF. Comparative morphology of Lacazia loboi (syn. Loboa loboi) in dolphins and humans. Med Mycol. 2000;38:9–14.
- Mendoza L, Belone AF, Vilela R, Rehtanz M, Bossart GD, Reif JS, Use of sera from humans and dolphins with lacaziosis and sera from experimentally infected mice for Western blot analyses of Lacazia loboi antigens. Clin Vaccine Immunol. 2008;15:164–7.
- Pecher SA, Fuchs J. Cellular immunity in lobomycosis (keloidal blastomycosis). Allergol Immunopathol (Madr). 1988;16:413–5.
- Figure 1. A) Multiple, confluent, keloid-like, hyperchromic nodules with flat shiny surfaces involving the entire free border, posterior aspect, and lobule of the left ear of a fisherman, Venezuela. B) Numerous...
- Figure 2. Extensive lobomycosis-like disease on the beak (A) and dorsal fin (B) of a bottlenose dolphin (Tursiops truncatus) stranded on Margarita Island, Venezuela.
Suggested citation for this article: Bermudez L, Van Bressem M-F, Reyes-Jaimes O, Sayegh AJ, Paniz Mondolfi AE. Lobomycosis in man and lobomycosis-like disease in bottlenose dolphin, Venezuela. Emerg Infect Dis [serial on the Internet]. 2009 Aug [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/8/09-0347
Please use the form below to submit correspondence to the authors or contact them at the following address:
Alberto E. Paniz-Mondolfi, Department of Pathology and Laboratory Medicine, St. Luke’s–Roosevelt–Beth Israel Medical Center, 1000 10th Ave, New York, NY 10019, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: November 01, 2010
- Page last updated: November 01, 2010
- Page last reviewed: November 01, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)